Antibiotic-resistant bacterial infections are difficult to treat and cause more than a million annual deaths worldwide, especially in hospitalized patients with pneumonia, bloodstream infections, urinary tract infections, ...
Mar 9, 2022
0
33
New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention.
Dec 30, 2021
1
118
New figures show global diabetes prevalence has increased by 16% in the past two years, with 537 million adults (aged 20–79) now estimated to be living with the chronic condition.
Dec 6, 2021
1
10
The U.S. Preventive Services Task Force is re-evaluating recommendations on the use of aspirin to prevent colorectal cancer. According to media reports and a review by the agency—charged since 1984 with issuing guidelines ...
Oct 25, 2021
0
6
Researchers from Cleveland Clinic and OhioHealth have published results from a first-in-human trial evaluating feasibility of Temporally Feathered Radiation Therapy (TFRT), which is designed to reduce the toxicity of radiation ...
Sep 1, 2021
0
1
According to a study published today in Gastroenterology by researchers at Virginia Commonwealth University Massey Cancer Center and University of Florida Health, Black, Hispanic, Indigenous and Asian Americans remain conspicuously ...
Aug 17, 2021
0
73
COVID-19 breakthrough infections—where a fully vaccinated person becomes infected with the coronavirus—are occurring across the globe, due, in large part, to the highly contagious Delta variant. Here in the United States, ...
Aug 13, 2021
0
7
An experimental COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac is 91.25% effective, a Turkish health official said on Thursday.
Dec 25, 2020
0
13
It's been a busy week or so for news about COVID vaccines. First we heard preliminary clinical trial results from the Pfizer vaccine, then the Russian Sputnik V vaccine. This week, we heard about the Moderna vaccine. All ...
Nov 19, 2020
0
2
Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.
Aug 15, 2020
0
4
